Today, the lack of timely testing capabilities in biopharma manufacturing can cost companies millions.....................................................................................................................................................
| Unsubscribe Today, the lack of timely testing capabilities in biopharma manufacturing can cost companies millions. Biopharmaceutical manufacturers must manage the risk of microbial contaminants — but the solutions on the market aren't fast, easy to use, or accurate enough.
Enter LexaGene. This company's cutting edge technology for human and animal biopharma manufacturing is redefining a major industry.
Register for the Webinar
LexaGene is a molecular testing company pioneering MiQLab®1, a rapid, automated pathogen detection system designed to revolutionize microbial contaminant detection. The proceeds of this financing will be used to create the 2nd generation system to meet the unmet needs of the biopharma manufacturing industry.
Tackling a manufacturing microbial contamination detection market with an estimated annual TAM of ~$2.0 billion2, LexaGene is on track to solve real, costly problems for biopharma manufacturers.
Accredited investors only stand to win.
LexaGene is running an exclusive webinar for accredited investors on Monday, March 18th, 2024 at 2 PM ET. The event will be hosted by LexaGene CEO Tom Forte, as well as the company's CTO, Dr. Jack Regan.
Sign up today to hear more about their leading class technology, the market opportunity, and how investors will benefit.
Register Now
1 MiQLab® Systems shown are the current model which will serve as the basis for rebuilding the next generation system. 2 Commissioned market research conducted by Fletcher Spaght Inc. | |
This is a PAID ADVERTISEMENT provided to the subscribers of StockEarnings Free Newsletter. Although we have sent you this email, StockEarnings does not specifically endorse this product nor is it responsible for the content of this advertisement. Furthermore, we make no guarantee or warranty about what is advertised above.
Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please click Unsubscribe . StockEarnings, Inc
33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA
W: 877.6.STOCKS
StockEarnings.com
No comments:
Post a Comment